Veratrylamine → HCID 118113931, compound
Reaction equation
[CH3:1][O:2][C:3]1[CH:4]=[C:5]([CH2:11][NH2:12])[CH:6]=[CH:7][C:8]=1[O:9][CH3:10].[Br:13][C:14]1[CH:15]=[CH:16][C:17]2[N:18]([CH:20]=[C:21]([C:23](OCC)=[O:24])[N:22]=2)[CH:19]=1>>[Br:13][C:14]1[CH:15]=[CH:16][C:17]2[N:18]([CH:20]=[C:21]([C:23]([NH:12][CH2:11][C:5]3[CH:6]=[CH:7][C:8]([O:9][CH3:10])=[C:3]([O:2][CH3:1])[CH:4]=3)=[O:24])[N:22]=2)[CH:19]=1Participants
3
Procedure
The title compound was prepared by essentially following the same procedures described for Intermediate I, using (3,4-dimethoxyphenyl)methanamine and ethyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate as starting materials.
Sources & evidence
- ORD record
- ord-1d20ba7682d24bb6b50bd8b1ed0de881
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09271969B2
Reaction notes
Loading…